8-K Announcements
6Material company update
Apr 23, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Feb 25, 2026·SEC
Chemed Corporation(CHE)Earnings, Financials & Key Ratios
CHE•NYSE
$424.56
$5.81B mkt cap·23.0× P/E·Price updated May 6, 2026
AboutChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Show more
- Revenue$2.53B+4.1%
- EBITDA$403M-6.2%
- Net Income$265M-12.2%
- EPS (Diluted)18.42-7.4%
- Gross Margin29.97%-14.7%
- EBITDA Margin15.93%-9.8%
- Operating Margin13.37%-11.3%
- Net Margin10.48%-15.6%
- ROE25.28%-6.8%
- ROIC23.7%-10.3%
- Debt/Equity0.16+25.5%
- Interest Coverage204.30-9.4%
CHE Key Insights
Chemed Corporation (CHE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 27.0%
- ✓18 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 5.2% through buybacks
- ✓Healthy 5Y average net margin of 11.8%
- ✓Efficient asset utilization: 1.5x turnover
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CHE Price & Volume
Chemed Corporation (CHE) stock price & volume — 10-year historical chart
Loading chart...
CHE Growth Metrics
Chemed Corporation (CHE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.07%
5 Years4%
3 Years5.82%
TTM2.07%
Profit CAGR
10 Years9.17%
5 Years-3.65%
3 Years2.04%
TTM-15.86%
EPS CAGR
10 Years11.27%
5 Years-1.11%
3 Years3.67%
TTM-10.66%
Return on Capital
10 Years28.06%
5 Years28.34%
3 Years26.24%
Last Year24.73%
CHE Recent Earnings
Chemed Corporation (CHE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
Apr 23, 2026EPS
$5.65
Est $5.30
+6.6%
Revenue
$658M
Est $650M
+1.2%
Q1 2026
Feb 25, 2026EPS
$6.42
Est $7.02
-8.5%
Revenue
$639M
Est $659M
-3.0%
Q4 2025
Oct 28, 2025EPS
$5.27
Est $5.39
-2.2%
Revenue
$625M
Est $659M
-5.2%
Q3 2025
Jul 29, 2025EPS
$4.27
Est $4.78
-10.7%
Revenue
$619M
Est $631M
-2.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 23, 2026 | $5.65vs $5.30+6.6% | $658Mvs $650M+1.2% |
| Q1 2026 | Feb 25, 2026 | $6.42vs $7.02-8.5% | $639Mvs $659M-3.0% |
| Q4 2025 | Oct 28, 2025 | $5.27vs $5.39-2.2% | $625Mvs $659M-5.2% |
| Q3 2025 | Jul 29, 2025 | $4.27vs $4.78-10.7% | $619Mvs $631M-2.0% |
Based on last 12 quarters of dataView full earnings history →
CHE Peer Comparison
Chemed Corporation (CHE) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ADUS | 1.8B | 96.64 | 18.55 | 23.21% | 6.89% | 9.34% | 0.19 | |
 ENSG | 10.28B | 175.93 | 30.13 | 18.72% | 6.89% | 16.61% | 1.86 | |
 SCI | 10.88B | 78.44 | 20.64 | 2.93% | 14.46% | 39.44% | 3.14 | |
 CSV | 738.65M | 46.57 | 14.33 | 3.28% | 10.56% | 17.6% | 2.21 | |
 HCSG | 1.58B | 22.07 | 27.25 | 7.08% | 3.21% | 11.83% | 0.05 | |
 OPCH | 3.2B | 20.45 | 16.10 | 13.03% | 3.64% | 15.28% | ||
 UNH | 333.37B | 367.28 | 27.76 | 11.81% | 2.68% | 11.54% | 0.77 | |
 HUM | 29.57B | 246.33 | 25.03 | 10.06% | 0.82% | 6.17% | 0.73 |
Compare CHE vs Peers
Chemed Corporation (CHE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CHE Income Statement
Chemed Corporation (CHE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.67B | 1.78B | 1.94B | 2.08B | 2.14B | 2.13B | 2.26B | 2.43B | 2.53B | 2.54B |
| Revenue Growth % | 5.7% | 6.96% | 8.75% | 7.27% | 2.87% | -0.2% | 6.06% | 7.37% | 4.06% | 2.07% |
| Cost of Goods Sold | 1.15B | 1.23B | 1.32B | 1.38B | 1.37B | 1.37B | 1.47B | 1.58B | 1.77B | 1.31B |
| COGS % of Revenue | 69.03% | 68.87% | 68.15% | 66.27% | 64.02% | 64.16% | 64.72% | 64.86% | 70.03% | - |
| Gross Profit | 516.19M▲ 0% | 555M▲ 7.5% | 617.43M▲ 11.2% | 701.39M▲ 13.6% | 769.8M▲ 9.8% | 765.09M▼ 0.6% | 798.82M▲ 4.4% | 854.35M▲ 7.0% | 758.34M▼ 11.2% | 571.36M▲ 0% |
| Gross Margin % | 30.97% | 31.13% | 31.85% | 33.73% | 35.98% | 35.84% | 35.28% | 35.14% | 29.97% | 22.49% |
| Gross Profit Growth % | 11.86% | 7.52% | 11.25% | 13.6% | 9.75% | -0.61% | 4.41% | 6.95% | -11.24% | - |
| Operating Expenses | 403.16M | 311.37M | 360.05M | 311.71M | 426.76M | 421.59M | 458.25M | 487.86M | 417.19M | 442.21M |
| OpEx % of Revenue | 24.19% | 17.47% | 18.57% | 14.99% | 19.95% | 19.75% | 20.24% | 20.07% | 16.49% | - |
| Selling, General & Admin | 276.65M | 271.21M | 305.71M | 330.22M | 366.73M | 358.73M | 395.12M | 424.36M | 417.19M | 425M |
| SG&A % of Revenue | 16.6% | 15.21% | 15.77% | 15.88% | 17.14% | 16.8% | 17.45% | 17.45% | 16.49% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 126.5M | 40.16M | 54.34M | -18.51M | 60.04M | 62.86M | 63.13M | 63.49M | 0 | 1000K |
| Operating Income | 113.03M▲ 0% | 243.63M▲ 115.5% | 257.38M▲ 5.6% | 389.68M▲ 51.4% | 343.04M▼ 12.0% | 343.5M▲ 0.1% | 340.57M▼ 0.9% | 366.49M▲ 7.6% | 338.25M▼ 7.7% | 328.07M▲ 0% |
| Operating Margin % | 6.78% | 13.67% | 13.28% | 18.74% | 16.04% | 16.09% | 15.04% | 15.07% | 13.37% | 12.91% |
| Operating Income Growth % | -36.76% | 115.54% | 5.64% | 51.4% | -11.97% | 0.13% | -0.85% | 7.61% | -7.71% | - |
| EBITDA | 148.66M | 282.5M | 302.58M | 446.26M | 402.09M | 402.67M | 401.43M | 429.54M | 403.09M | 376.89M |
| EBITDA Margin % | 8.92% | 15.85% | 15.61% | 21.46% | 18.8% | 18.86% | 17.73% | 17.67% | 15.93% | 14.84% |
| EBITDA Growth % | -30.33% | 90.03% | 7.11% | 47.48% | -9.9% | 0.14% | -0.31% | 7% | -6.16% | -16.65% |
| D&A (Non-Cash Add-back) | 35.63M | 38.86M | 45.2M | 56.58M | 59.05M | 59.17M | 60.87M | 63.05M | 64.84M | 48.82M |
| EBIT | 121.19M | 244.59M | 266.14M | 398.35M | 352.18M | 334.26M | 353.48M | 401.25M | 357.53M | 263.07M |
| Net Interest Income | -3.85M | -4.32M | -4.02M | -1.6M | -1.49M | -4.23M | 3.16M | 12.83M | 7M | 5.78M |
| Interest Income | 427K | 671K | 513K | 757K | 377K | 355K | 6.27M | 14.61M | 8.74M | 9.63M |
| Interest Expense | 4.27M | 4.99M | 4.54M | 2.35M | 1.87M | 4.58M | 3.11M | 1.78M | 1.75M | 2.45M |
| Other Income/Expense | 3.88M | -4.03M | 4.23M | 6.31M | 7.28M | -13.82M | 9.8M | 32.97M | 17.53M | 20.88M |
| Pretax Income | 116.92M▲ 0% | 239.6M▲ 104.9% | 261.61M▲ 9.2% | 395.99M▲ 51.4% | 350.31M▼ 11.5% | 329.68M▼ 5.9% | 350.37M▲ 6.3% | 399.46M▲ 14.0% | 355.78M▼ 10.9% | 348.94M▲ 0% |
| Pretax Margin % | 7.01% | 13.44% | 13.5% | 19.04% | 16.38% | 15.44% | 15.47% | 16.43% | 14.06% | 13.73% |
| Income Tax | 18.74M | 34.06M | 41.69M | 76.52M | 81.76M | 80.06M | 77.86M | 97.47M | 90.54M | 89.16M |
| Effective Tax Rate % | 16.03% | 14.21% | 15.93% | 19.32% | 23.34% | 24.28% | 22.22% | 24.4% | 25.45% | 25.55% |
| Net Income | 98.18M▲ 0% | 205.54M▲ 109.4% | 219.92M▲ 7.0% | 319.47M▲ 45.3% | 268.55M▼ 15.9% | 249.62M▼ 7.0% | 272.51M▲ 9.2% | 302M▲ 10.8% | 265.24M▼ 12.2% | 259.78M▲ 0% |
| Net Margin % | 5.89% | 11.53% | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 12.42% | 10.48% | 10.23% |
| Net Income Growth % | -9.72% | 109.36% | 7% | 45.26% | -15.94% | -7.05% | 9.17% | 10.82% | -12.17% | -15.86% |
| Net Income (Continuing) | 98.18M | 205.54M | 219.92M | 319.47M | 268.55M | 249.62M | 272.51M | 302M | 265.24M | 259.78M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 5.86▲ 0% | 12.23▲ 108.7% | 13.31▲ 8.8% | 19.48▲ 46.4% | 16.85▼ 13.5% | 16.53▼ 1.9% | 17.93▲ 8.5% | 19.89▲ 10.9% | 18.42▼ 7.4% | 19.00▲ 0% |
| EPS Growth % | -9.57% | 108.7% | 8.83% | 46.36% | -13.5% | -1.9% | 8.47% | 10.93% | -7.39% | -10.66% |
| EPS (Basic) | 6.11 | 12.80 | 13.77 | 20.02 | 17.14 | 16.72 | 18.11 | 20.10 | 18.42 | - |
| Diluted Shares Outstanding | 16.74M | 16.8M | 16.53M | 16.4M | 15.94M | 15.1M | 15.2M | 15.19M | 14.4M | 13.68M |
| Basic Shares Outstanding | 16.06M | 16.06M | 15.97M | 15.96M | 15.67M | 14.93M | 15.05M | 15.02M | 14.4M | 13.68M |
| Dividend Payout Ratio | 17.69% | 9.08% | 9% | 6.6% | 8.2% | 8.82% | 8.62% | 8.97% | 11.95% | - |
CHE Balance Sheet
Chemed Corporation (CHE) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 176.05M | 159.84M | 190.67M | 329.4M | 230.29M | 272.61M | 500.84M | 394.75M | 302.62M | 274.06M |
| Cash & Short-Term Investments | 11.12M | 4.83M | 6.16M | 162.68M | 32.9M | 74.13M | 263.96M | 178.35M | 74.52M | 16.86M |
| Cash Only | 11.12M | 4.83M | 6.16M | 162.68M | 32.9M | 74.13M | 263.96M | 178.35M | 74.52M | 16.86M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 113.65M | 119.5M | 143.83M | 126.85M | 137.22M | 139.41M | 181.51M | 171.16M | 182.57M | 215.48M |
| Days Sales Outstanding | 24.89 | 24.47 | 27.08 | 22.26 | 23.41 | 23.83 | 29.26 | 25.7 | 26.34 | 28.68 |
| Inventory | 5.33M | 5.71M | 7.46M | 7.09M | 10.11M | 10.27M | 12M | 8.19M | 7.54M | 7.21M |
| Days Inventory Outstanding | 1.69 | 1.7 | 2.06 | 1.88 | 2.69 | 2.74 | 2.99 | 1.9 | 1.55 | 2.24 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.52M |
| Total Non-Current Assets | 743.98M | 815.69M | 1.08B | 1.11B | 1.11B | 1.17B | 1.17B | 1.27B | 1.34B | 1.26B |
| Property, Plant & Equipment | 143.03M | 162.03M | 287.42M | 311.27M | 318.73M | 335.38M | 330.23M | 328.16M | 336.81M | 133.6M |
| Fixed Asset Turnover | 11.65x | 11.00x | 6.74x | 6.68x | 6.71x | 6.37x | 6.86x | 7.41x | 7.51x | 8.94x |
| Goodwill | 476.89M | 510.57M | 577.37M | 578.59M | 578.59M | 581.29M | 585.02M | 666.74M | 667M | 687.5M |
| Intangible Assets | 54.87M | 68.25M | 126.37M | 118.08M | 108.1M | 99.73M | 90.26M | 92.21M | 82.76M | 80.42M |
| Long-Term Investments | 62.07M | 65.62M | 77.45M | 88.81M | 98.88M | 0 | 0 | 0 | 140.35M | 284.13M |
| Other Non-Current Assets | 7.13M | 9.21M | 9.05M | 8.76M | 8.14M | 153M | 161.74M | 186.72M | 8.65M | 507.15M |
| Total Assets | 920.03M▲ 0% | 975.53M▲ 6.0% | 1.27B▲ 30.0% | 1.43B▲ 13.1% | 1.34B▼ 6.4% | 1.44B▲ 7.4% | 1.67B▲ 15.7% | 1.67B▲ 0.0% | 1.64B▼ 1.7% | 1.54B▲ 0% |
| Asset Turnover | 1.81x | 1.83x | 1.53x | 1.45x | 1.59x | 1.48x | 1.36x | 1.46x | 1.54x | 1.56x |
| Asset Growth % | 4.54% | 6.03% | 30.01% | 13.13% | -6.42% | 7.39% | 15.68% | 0.03% | -1.71% | -21.99% |
| Total Current Liabilities | 193.52M | 191.67M | 262.22M | 299.11M | 302.4M | 297.2M | 312.05M | 285.69M | 287.13M | 321.42M |
| Accounts Payable | 48.37M | 50.15M | 51.1M | 54.23M | 73.02M | 41.88M | 64.03M | 44.15M | 53.46M | 65.7M |
| Days Payables Outstanding | 15.35 | 14.91 | 14.12 | 14.36 | 19.46 | 11.16 | 15.95 | 10.22 | 11.01 | 15.17 |
| Short-Term Debt | 10M | 0 | 0 | 0 | 0 | 5M | 15.7M | 0 | 51.89M | 41.29M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 86.4M | 93.57M | 114.44M | 133.88M | 134.63M | 145.84M | 121.87M | 134.75M | 120.95M | 280.13M |
| Current Ratio | 0.91x | 0.83x | 0.73x | 1.10x | 0.76x | 0.92x | 1.61x | 1.38x | 1.05x | 1.05x |
| Quick Ratio | 0.88x | 0.80x | 0.70x | 1.08x | 0.73x | 0.88x | 1.57x | 1.35x | 1.03x | 1.03x |
| Cash Conversion Cycle | 11.24 | 11.25 | 15.02 | 9.78 | 6.64 | 15.41 | 16.3 | 17.37 | 16.88 | 15.74 |
| Total Non-Current Liabilities | 186.15M | 192.53M | 279.49M | 234.6M | 417.05M | 346.09M | 248.17M | 263.89M | 373.48M | 366.41M |
| Long-Term Debt | 91.2M | 89.2M | 90M | 0 | 185M | 92.5M | 0 | 0 | 0 | 195.65M |
| Capital Lease Obligations | -61.8M | 0 | 86.66M | 99.21M | 100.63M | 110.51M | 100.78M | 98.54M | 102.87M | 304.19M |
| Deferred Tax Liabilities | 16.64M | 21.6M | 18.5M | 20.66M | 23.18M | 38.61M | 30.32M | 25.95M | 121.14M | 158.1M |
| Other Non-Current Liabilities | 78.31M | 81.73M | 84.33M | 114.73M | 108.24M | 104.47M | 117.07M | 139.4M | 13.34M | 456.18M |
| Total Liabilities | 379.67M | 384.19M | 541.71M | 533.71M | 719.45M | 643.3M | 560.22M | 549.58M | 660.61M | 687.82M |
| Total Debt | 101.2M | 89.2M | 215.94M | 135.41M | 323.54M | 247.01M | 155.11M | 140.84M | 154.76M | 236.93M |
| Net Debt | 90.08M | 84.37M | 209.78M | -27.27M | 290.65M | 172.88M | -108.85M | -37.51M | 80.24M | 220.08M |
| Debt / Equity | 0.19x | 0.15x | 0.30x | 0.15x | 0.52x | 0.31x | 0.14x | 0.13x | 0.16x | 0.16x |
| Debt / EBITDA | 0.68x | 0.32x | 0.71x | 0.30x | 0.80x | 0.61x | 0.39x | 0.33x | 0.38x | 0.63x |
| Net Debt / EBITDA | 0.61x | 0.30x | 0.69x | -0.06x | 0.72x | 0.43x | -0.27x | -0.09x | 0.20x | 0.20x |
| Interest Coverage | 28.37x | 49.02x | 58.69x | 169.15x | 188.53x | 72.92x | 113.73x | 225.42x | 204.30x | 107.24x |
| Total Equity | 540.35M▲ 0% | 591.33M▲ 9.4% | 726.61M▲ 22.9% | 901.2M▲ 24.0% | 623.27M▼ 30.8% | 798.72M▲ 28.1% | 1.11B▲ 38.7% | 1.12B▲ 1.0% | 979.4M▼ 12.5% | 847.99M▲ 0% |
| Equity Growth % | 3.1% | 9.43% | 22.88% | 24.03% | -30.84% | 28.15% | 38.71% | 1% | -12.47% | -54.32% |
| Book Value per Share | 32.28 | 35.19 | 43.96 | 54.96 | 39.11 | 52.90 | 72.89 | 73.69 | 68.02 | 62.01 |
| Total Shareholders' Equity | 540.35M | 591.33M | 726.61M | 901.2M | 623.27M | 798.72M | 1.11B | 1.12B | 979.4M | 847.99M |
| Common Stock | 34.73M | 35.31M | 35.81M | 36.26M | 36.51M | 36.8M | 37.18M | 37.42M | 37.59M | 0 |
| Retained Earnings | 1.04B | 1.23B | 1.43B | 1.72B | 1.97B | 2.2B | 2.45B | 2.72B | 2.96B | 3.01B |
| Treasury Stock | -1.23B | -1.45B | -1.6B | -1.82B | -2.43B | -2.59B | -2.72B | -3.13B | -3.61B | 0 |
| Accumulated OCI | 2.2M | 2.34M | 2.31M | 2.34M | 0 | 0 | 0 | 0 | 2.35M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CHE Cash Flow Statement
Chemed Corporation (CHE) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 162.5M | 287.14M | 301.25M | 489.29M | 308.6M | 309.89M | 330.3M | 417.5M | 388.27M | 388.27M |
| Operating CF Margin % | 9.75% | 16.11% | 15.54% | 23.53% | 14.43% | 14.51% | 14.59% | 17.17% | 15.35% | - |
| Operating CF Growth % | 20.02% | 76.71% | 4.91% | 62.42% | -36.93% | 0.42% | 6.59% | 26.4% | -7% | 221.32% |
| Net Income | 98.18M | 205.54M | 219.92M | 319.47M | 268.55M | 249.62M | 272.51M | 302M | 265.24M | 259.78M |
| Depreciation & Amortization | 35.63M | 38.86M | 45.2M | 56.58M | 59.05M | 59.17M | 60.87M | 63.05M | 64.84M | 65.7M |
| Stock-Based Compensation | 1.23M | 446K | 14.83M | 18.42M | 22.5M | 26.25M | 30.08M | 32.03M | 4.89M | 18.89M |
| Deferred Taxes | 2.41M | 5.19M | -2.77M | 37.78M | -15.78M | -3.35M | -8.03M | -4.14M | -5.94M | 3.49M |
| Other Non-Cash Items | 29.05M | 7.33M | 16.48M | 12.61M | 1.07M | 11.67M | 14.18M | 16.42M | 35.54M | 19.77M |
| Working Capital Changes | -14.48M | 17.15M | 7.58M | 44.43M | -26.8M | -33.49M | -39.31M | 8.13M | 23.71M | 76.12M |
| Change in Receivables | 1.07M | -5.57M | -19.25M | 12.77M | -8.43M | -2.41M | -41.49M | 10.68M | -11.6M | 22.93M |
| Change in Inventory | 421K | -351K | -1.76M | 367K | -3.01M | -162K | -1.73M | 3.83M | 650K | 582K |
| Change in Payables | 12.89M | 8.94M | 28.42M | 19.1M | 9.83M | 15.34M | -9.35M | -9.28M | -5.19M | 17.4M |
| Cash from Investing | -67.61M | -105.22M | -190.76M | -61.56M | -57.76M | -59.4M | -60.64M | -143.91M | -59.34M | -83.45M |
| Capital Expenditures | -64.3M | -52.87M | -53.02M | -58.83M | -58.67M | -57.33M | -56.85M | -49.53M | -62.8M | -66.63M |
| CapEx % of Revenue | 3.86% | 2.97% | 2.74% | 2.83% | 2.74% | 2.69% | 2.51% | 2.04% | 2.48% | - |
| Acquisitions | -4.72M | -53.18M | -138.01M | -3.6M | 0 | -3.53M | -3.99M | -97.4M | -225K | -20.61M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.42M | 824K | 272K | 871K | 918K | 1.45M | 206K | 3.02M | 3.68M | 3.79M |
| Cash from Financing | -99.08M | -188.2M | -109.16M | -271.21M | -380.62M | -209.25M | -79.83M | -359.19M | -432.77M | -517.32M |
| Debt Issued (Net) | -850K | -13.53M | 800K | -90M | 196.88M | -99.38M | -81.75M | -15.75M | 10.97M | 10.53M |
| Equity Issued (Net) | -94.64M | -158.88M | -92.63M | -175.59M | -576.04M | -114.52M | -67.7M | -361.39M | -404.35M | -398.28M |
| Dividends Paid | -17.37M | -18.66M | -19.79M | -21.08M | -22.02M | -22.02M | -23.5M | -27.09M | -31.7M | -32.54M |
| Share Repurchases | -94.64M | -158.88M | -92.63M | -175.59M | -576.04M | -114.52M | -67.7M | -361.39M | -431.5M | -588.32M |
| Other Financing | 13.79M | 2.87M | 2.46M | 15.46M | 20.55M | 26.66M | 93.13M | 45.04M | -7.69M | -97.03M |
| Net Change in Cash | -4.19M▲ 0% | -6.29M▼ 50.2% | 1.33M▲ 121.1% | 156.52M▲ 11694.8% | -129.78M▼ 182.9% | 41.23M▲ 131.8% | 189.83M▲ 360.4% | -85.61M▼ 145.1% | -103.83M▼ 21.3% | -157.03M▲ 0% |
| Free Cash Flow | 98.19M▲ 0% | 234.27M▲ 138.6% | 248.23M▲ 6.0% | 430.46M▲ 73.4% | 249.92M▼ 41.9% | 252.56M▲ 1.1% | 273.44M▲ 8.3% | 367.97M▲ 34.6% | 325.48M▼ 11.5% | 377.12M▲ 0% |
| FCF Margin % | 5.89% | 13.14% | 12.8% | 20.7% | 11.68% | 11.83% | 12.08% | 15.13% | 12.86% | 14.84% |
| FCF Growth % | 2.69% | 138.57% | 5.96% | 73.41% | -41.94% | 1.06% | 8.27% | 34.57% | -11.55% | 19.7% |
| FCF per Share | 5.87 | 13.94 | 15.02 | 26.25 | 15.68 | 16.73 | 17.99 | 24.23 | 22.61 | 22.61 |
| FCF Conversion (FCF/Net Income) | 1.66x | 1.40x | 1.37x | 1.53x | 1.15x | 1.24x | 1.21x | 1.38x | 1.46x | 1.45x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CHE Key Ratios
Chemed Corporation (CHE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 18.45% | 36.33% | 33.37% | 39.25% | 35.23% | 35.11% | 28.59% | 27.12% | 25.28% | 25.33% |
| Return on Invested Capital (ROIC) | 13.59% | 27.98% | 23.95% | 32.29% | 28.78% | 27.33% | 25.92% | 26.42% | 23.7% | 23.7% |
| Gross Margin | 30.97% | 31.13% | 31.85% | 33.73% | 35.98% | 35.84% | 35.28% | 35.14% | 29.97% | 22.49% |
| Net Margin | 5.89% | 11.53% | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 12.42% | 10.48% | 10.23% |
| Debt / Equity | 0.19x | 0.15x | 0.30x | 0.15x | 0.52x | 0.31x | 0.14x | 0.13x | 0.16x | 0.16x |
| Interest Coverage | 28.37x | 49.02x | 58.69x | 169.15x | 188.53x | 72.92x | 113.73x | 225.42x | 204.30x | 107.24x |
| FCF Conversion | 1.66x | 1.40x | 1.37x | 1.53x | 1.15x | 1.24x | 1.21x | 1.38x | 1.46x | 1.45x |
| Revenue Growth | 5.7% | 6.96% | 8.75% | 7.27% | 2.87% | -0.2% | 6.06% | 7.37% | 4.06% | 2.07% |
CHE SEC Filings & Documents
Chemed Corporation (CHE) SEC filings — annual & quarterly reports (10-K, 10-Q)
CHE Frequently Asked Questions
Chemed Corporation (CHE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Chemed Corporation (CHE) reported $2.54B in revenue for fiscal year 2025. This represents a 743% increase from $301.2M in 1996.
Chemed Corporation (CHE) grew revenue by 4.1% over the past year. Growth has been modest.
Yes, Chemed Corporation (CHE) is profitable, generating $259.8M in net income for fiscal year 2025 (10.5% net margin).
Dividend & Returns
Yes, Chemed Corporation (CHE) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.
Chemed Corporation (CHE) has a return on equity (ROE) of 25.3%. This is excellent, indicating efficient use of shareholder capital.
Chemed Corporation (CHE) generated $377.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More CHE
Chemed Corporation (CHE) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates